Selected research
Industry Research
SPECT Radiopharmaceuticals Industry Research Report 2026
Market perspective
The global SPECT Radiopharmaceuticals market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the SPECT Radiopharmaceuticals market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the SPECT Radiopharmaceuticals market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the SPECT Radiopharmaceuticals market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of SPECT Radiopharmaceuticals include Siemens Healthineers, NorthStar Medical Radioisotopes, Molecular Imaging, Inc., Lantheus Medical Imaging, IBA Molecular Imaging, GE Healthcare, Eczacibasi-Monrol, Curium Pharma and Cardinal Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global SPECT Radiopharmaceuticals market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to SPECT Radiopharmaceuticals.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
SPECT Radiopharmaceuticals Market by Company
Siemens Healthineers
NorthStar Medical Radioisotopes
Molecular Imaging, Inc.
Lantheus Medical Imaging
IBA Molecular Imaging
GE Healthcare
Eczacibasi-Monrol
Curium Pharma
Cardinal Health
Bracco Imaging
Bayer (Radiology Division)
Advanced Accelerator Applications
SPECT Radiopharmaceuticals Segment by Type
Indium-111 (In-111) Based Agents
Thallium-201 (Tl-201)
Gallium-67 (Ga-67)
Iodine-123 (I-123) Based Agents
Technetium-99m (Tc-99m) Based Agents
SPECT Radiopharmaceuticals Segment by Application
Cardiac Imaging
Brain Imaging
Thyroid Imaging
Infection and Inflammation Imaging
Cancer Imaging
SPECT Radiopharmaceuticals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SPECT Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of SPECT Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SPECT Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of SPECT Radiopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Indium-111 (In-111) Based Agents
- Thallium-201 (Tl-201)
- Gallium-67 (Ga-67)
- Iodine-123 (I-123) Based Agents
- Technetium-99m (Tc-99m) Based Agents
Applications
- Cardiac Imaging
- Brain Imaging
- Thyroid Imaging
- Infection and Inflammation Imaging
- Cancer Imaging
Companies covered
- Siemens Healthineers
- NorthStar Medical Radioisotopes
- Molecular Imaging, Inc.
- Lantheus Medical Imaging
- IBA Molecular Imaging
- GE Healthcare
- Eczacibasi-Monrol
- Curium Pharma
- Cardinal Health
- Bracco Imaging
- Bayer (Radiology Division)
- Advanced Accelerator Applications
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 SPECT Radiopharmaceuticals by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Indium-111 (In-111) Based Agents
- 2.2.3 Thallium-201 (Tl-201)
- 2.2.4 Gallium-67 (Ga-67)
- 2.2.5 Iodine-123 (I-123) Based Agents
- 2.2.6 Technetium-99m (Tc-99m) Based Agents
- 2.3 SPECT Radiopharmaceuticals by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cardiac Imaging
- 2.3.3 Brain Imaging
- 2.3.4 Thyroid Imaging
- 2.3.5 Infection and Inflammation Imaging
- 2.3.6 Cancer Imaging
- 2.4 Assumptions and Limitations
3 SPECT Radiopharmaceuticals Breakdown Data by Type
- 3.1 Global SPECT Radiopharmaceuticals Historic Market Size by Type (2021-2026)
- 3.2 Global SPECT Radiopharmaceuticals Forecasted Market Size by Type (2027-2032)
4 SPECT Radiopharmaceuticals Breakdown Data by Application
- 4.1 Global SPECT Radiopharmaceuticals Historic Market Size by Application (2021-2026)
- 4.2 Global SPECT Radiopharmaceuticals Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global SPECT Radiopharmaceuticals Market Perspective (2021-2032)
- 5.2 Global SPECT Radiopharmaceuticals Growth Trends by Region
- 5.2.1 Global SPECT Radiopharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 SPECT Radiopharmaceuticals Historic Market Size by Region (2021-2026)
- 5.2.3 SPECT Radiopharmaceuticals Forecasted Market Size by Region (2027-2032)
- 5.3 SPECT Radiopharmaceuticals Market Dynamics
- 5.3.1 SPECT Radiopharmaceuticals Industry Trends
- 5.3.2 SPECT Radiopharmaceuticals Market Drivers
- 5.3.3 SPECT Radiopharmaceuticals Market Challenges
- 5.3.4 SPECT Radiopharmaceuticals Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top SPECT Radiopharmaceuticals Players by Revenue
- 6.1.1 Global Top SPECT Radiopharmaceuticals Players by Revenue (2021-2026)
- 6.1.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Players (2021-2026)
- 6.2 Global SPECT Radiopharmaceuticals Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of SPECT Radiopharmaceuticals Head Office and Area Served
- 6.4 Global SPECT Radiopharmaceuticals Players, Product Type & Application
- 6.5 Global SPECT Radiopharmaceuticals Manufacturers Established Date
- 6.6 Global SPECT Radiopharmaceuticals Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America SPECT Radiopharmaceuticals Market Size (2021-2032)
- 7.2 North America SPECT Radiopharmaceuticals Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 7.4 North America SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe SPECT Radiopharmaceuticals Market Size (2021-2032)
- 8.2 Europe SPECT Radiopharmaceuticals Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 8.4 Europe SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific SPECT Radiopharmaceuticals Market Size (2021-2032)
- 9.2 Asia-Pacific SPECT Radiopharmaceuticals Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 9.4 Asia-Pacific SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America SPECT Radiopharmaceuticals Market Size (2021-2032)
- 10.2 South America SPECT Radiopharmaceuticals Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 10.4 South America SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa SPECT Radiopharmaceuticals Market Size (2021-2032)
- 11.2 Middle East & Africa SPECT Radiopharmaceuticals Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 11.4 Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens Healthineers
- 12.1.1 Siemens Healthineers Company Information
- 12.1.2 Siemens Healthineers Business Overview
- 12.1.3 Siemens Healthineers Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.1.4 Siemens Healthineers SPECT Radiopharmaceuticals Product Portfolio
- 12.1.5 Siemens Healthineers Recent Developments
- 12.2 NorthStar Medical Radioisotopes
- 12.2.1 NorthStar Medical Radioisotopes Company Information
- 12.2.2 NorthStar Medical Radioisotopes Business Overview
- 12.2.3 NorthStar Medical Radioisotopes Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.2.4 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product Portfolio
- 12.2.5 NorthStar Medical Radioisotopes Recent Developments
- 12.3 Molecular Imaging, Inc.
- 12.3.1 Molecular Imaging, Inc. Company Information
- 12.3.2 Molecular Imaging, Inc. Business Overview
- 12.3.3 Molecular Imaging, Inc. Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.3.4 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product Portfolio
- 12.3.5 Molecular Imaging, Inc. Recent Developments
- 12.4 Lantheus Medical Imaging
- 12.4.1 Lantheus Medical Imaging Company Information
- 12.4.2 Lantheus Medical Imaging Business Overview
- 12.4.3 Lantheus Medical Imaging Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.4.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Portfolio
- 12.4.5 Lantheus Medical Imaging Recent Developments
- 12.5 IBA Molecular Imaging
- 12.5.1 IBA Molecular Imaging Company Information
- 12.5.2 IBA Molecular Imaging Business Overview
- 12.5.3 IBA Molecular Imaging Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.5.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Portfolio
- 12.5.5 IBA Molecular Imaging Recent Developments
- 12.6 GE Healthcare
- 12.6.1 GE Healthcare Company Information
- 12.6.2 GE Healthcare Business Overview
- 12.6.3 GE Healthcare Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.6.4 GE Healthcare SPECT Radiopharmaceuticals Product Portfolio
- 12.6.5 GE Healthcare Recent Developments
- 12.7 Eczacibasi-Monrol
- 12.7.1 Eczacibasi-Monrol Company Information
- 12.7.2 Eczacibasi-Monrol Business Overview
- 12.7.3 Eczacibasi-Monrol Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.7.4 Eczacibasi-Monrol SPECT Radiopharmaceuticals Product Portfolio
- 12.7.5 Eczacibasi-Monrol Recent Developments
- 12.8 Curium Pharma
- 12.8.1 Curium Pharma Company Information
- 12.8.2 Curium Pharma Business Overview
- 12.8.3 Curium Pharma Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.8.4 Curium Pharma SPECT Radiopharmaceuticals Product Portfolio
- 12.8.5 Curium Pharma Recent Developments
- 12.9 Cardinal Health
- 12.9.1 Cardinal Health Company Information
- 12.9.2 Cardinal Health Business Overview
- 12.9.3 Cardinal Health Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.9.4 Cardinal Health SPECT Radiopharmaceuticals Product Portfolio
- 12.9.5 Cardinal Health Recent Developments
- 12.10 Bracco Imaging
- 12.10.1 Bracco Imaging Company Information
- 12.10.2 Bracco Imaging Business Overview
- 12.10.3 Bracco Imaging Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.10.4 Bracco Imaging SPECT Radiopharmaceuticals Product Portfolio
- 12.10.5 Bracco Imaging Recent Developments
- 12.11 Bayer (Radiology Division)
- 12.11.1 Bayer (Radiology Division) Company Information
- 12.11.2 Bayer (Radiology Division) Business Overview
- 12.11.3 Bayer (Radiology Division) Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.11.4 Bayer (Radiology Division) SPECT Radiopharmaceuticals Product Portfolio
- 12.11.5 Bayer (Radiology Division) Recent Developments
- 12.12 Advanced Accelerator Applications
- 12.12.1 Advanced Accelerator Applications Company Information
- 12.12.2 Advanced Accelerator Applications Business Overview
- 12.12.3 Advanced Accelerator Applications Revenue in SPECT Radiopharmaceuticals Business (2021-2026)
- 12.12.4 Advanced Accelerator Applications SPECT Radiopharmaceuticals Product Portfolio
- 12.12.5 Advanced Accelerator Applications Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst